Who can postpone salvage radiotherapy in biochemically recurrent prostate cancer?

Salvage radiotherapy in biochemically recurrent prostate cancerПодробнее

Identification of High Risk Disease and Initial Management of Biochemical RecurrenceПодробнее

Biochemical Recurrence Post-radical ProstatectomyПодробнее

Winship Grand Rounds August 30, 2017: Alan Pollack, MD, PhDПодробнее

Use of salvage radiation therapy for biochemical recurrence of prostate cancer after prostatectomyПодробнее

PSA Recurrence: When Should You Treat? | Ask a Prostate Expert, Mark Scholz, MDПодробнее

When is adjuvant or salvage radiotherapy beneficial in prostate cancer?Подробнее

Dr. Einstein on Biochemical Recurrence in Prostate CancerПодробнее

Management of biochemical recurrence in prostate cancerПодробнее

PSMA PET guided salvage RT among patients with prostate cancer in the post-prostatectomy settingПодробнее

Plan B: Salvage Treatment for Prostate CancerПодробнее

Early Salvage Radiotherapy for Early Prostate CancerПодробнее

SALV-ENZA: SRT + enzalutamide in high-risk PSA-recurrent prostate cancer after radical prostatectomyПодробнее

Doctor Explains Radiation for Rising PSA after Prostate Cancer SurgeryПодробнее

Advances in salvage radiotherapy for prostate cancerПодробнее

Managing biochemical relapse after radical prostatectomyПодробнее

Prostate cancer: Biochemical recurrence after local therapy: what can I do?Подробнее

Dr. Johnstone on Immediate Salvage Therapy for Prostate CancerПодробнее

Evaluation and Management of Recurrent Prostate Cancer Following Radiation TherapyПодробнее

The treatment paradigm for prostate cancer patients with biochemical recurrence: Paul Nguyen, MDПодробнее

Optimizing outcomes in PSA recurrent prostate cancerПодробнее

Randomized Phase II Trial of Salvage Radiotherapy for Prostate Cancer in 4 Weeks v 2 Weeks (SHORTER)Подробнее